PICKERING GRANT 4

What Happened
Grant Pickering, CEO of Vaxcyte (PCVX), surrendered 3,685 shares of company stock to the issuer on March 9, 2026 to cover tax withholding obligations tied to vested restricted stock units (RSUs). The shares were valued at $59.32 each, for a total of about $218,594. This was a tax-withholding disposition (code F), not an open-market sale.

Key Details

• Transaction date and price: March 9, 2026 — 3,685 shares at $59.32 each (total ≈ $218,594).
• Transaction type: Code F — shares surrendered to the issuer to satisfy tax withholding on RSU vesting (cashless/tax-surrender).
• Shares owned after transaction: Not specified in this Form 4.
• Footnotes of note:
  • F1: Shares were surrendered solely to cover tax withholding on RSU vesting; no other restricted shares subject to the Jan 29, 2026 lock-up were sold.
  • F2/F3: Some shares are held in trusts for the Reporting Person’s son and daughter.
• Filing timeliness: Reported on March 11, 2026 for a March 9 transaction — appears to be filed on time under Form 4 reporting rules.

Context
Tax-withholding surrenders are routine when RSUs vest: the company retains/surrenders a portion of the vested shares to cover payroll taxes. Such transactions are administrative and do not necessarily reflect the insider’s view on the stock; they are not the same as open-market sales or purchases.